784 research outputs found
An Observation of Resistance Training History in Ultramarathon Runners and Implications on Performance
Please download pdf version here
Fluorescent Sensor Arrays Can Predict and Quantify the Composition of Multicomponent Bacterial Samples
Fast and reliable identification of infectious disease agents is among the most important challenges for the healthcare system. The discrimination of individual components of mixed infections represents a particularly difficult task. In the current study we further expand the functionality of a ratiometric sensor array technology based on small-molecule environmentally-sensitive organic dyes, which can be successfully applied for the analysis of mixed bacterial samples. Using pattern recognition methods and data from pure bacterial species, we demonstrate that this approach can be used to quantify the composition of mixtures, as well as to predict their components with the accuracy of ~80% without the need to acquire additional reference data. The described approach significantly expands the functionality of sensor arrays and provides important insights into data processing for the analysis of other complex samples
Draft Genome Sequence of a Mycobacterium avium Complex Isolate from a Broadbill Bird
Mycobacterium avium complex (MAC) organisms cause opportunistic infections in humans, yet their epidemiology remains poorly understood. They are slowly growing environmental and animal-associated mycobacteria that have little notoriety except for the strains that cause disseminated infections in HIV- infected humans (1). Most MAC organisms are classified taxonomically as a single species, M. avium, which is divided into at least four subspecies, M. avium subsp. avium, M. avium subsp. hominissuis, M. avium subsp. paratuberculosis, and M. avium subsp. silvaticum (2). The only other species in this group is M. intracellulare. Genotyping of this diverse bacterial group has been achieved using intergenic spacers (3) and rpoB sequence analysis (4, 5)
Effects of Caffeine on the Muscular Endurance, Perceived Pain, and Effort of Resistance Trained Women
Please download pdf version here
Deformabilidad en hormigones con agregados reciclados
Diversos trabajos han demostrado la factibilidad de elaborar hormigones con agregados reciclados, sin embargo sobre algunos aspectos poco explorados aún existen informaciones contrapuestas. Entre ellos se destacan el comportamiento diferido del hormigón (contracción y fluencia) y la capacidad de deformación en tracción (extensibilidad). Estas propiedades afectan directamente el grado de fisuración que puede tener una estructura de hormigón, lo que adquiere una significativa relevancia en la práctica, al considerar su vida en servicio. En este trabajo se presenta un estudio de la deformabilidad de hormigones que contienen 50 o 100 % de agregado grueso obtenido a partir de la trituración de losas de pavimento. Los resultados se comparan con los de otros dos hormigones elaborados con idénticas proporciones de materiales componentes variando el tipo de agregado grueso, piedra partida granítica o piedra partida cuarcítica. Se evaluaron la resistencia a tracción, la extensibilidad en flexión bajo cargas rápidas, y la fluencia en compresión. Bajo cargas de corta duración se encontró una deformabilidad creciente en el hormigón con mayor contenido de agregados reciclados, tanto en flexotracción como en compresión; también se midieron mayores valores de contracción libre y de fluencia. A partir de los resultados surge que es posible estimar la deformabilidad del hormigón con agregados reciclados siguiendo criterios similares a los aplicados en hormigones con agregados naturales; las diferencias de deformabilidad se pueden justificar considerando la menor rigidez del agregado reciclado.Different works have demonstrated the feasibility of elaborating concrete with recycled aggregates, nevertheless there is still opposite information about some aspects that have not been widely studied. The differed behaviour (shrinkage and creep) and the deformation capacity in tension (extensibility) of concrete are among them. These properties have a direct effect over the degree of cracking that can have a concrete structure so, considering its service life, they acquire a significant relevance in practice. This paper presents a study on the deformability of concretes that contain 50 or 100 % of coarse aggregate obtained from crushed pavement slabs. The results are compared with those obtained on other two concretes prepared with the same mixture proportions varying only the type of coarse aggregate, granitic crushed stone or quartzitic crushed stone. The tensile strength, extensibility in flexure under rapid rate of loading and creep in compression were evaluated. It was found that under short term loads the deformability of concrete increases with the content of recycled aggregates, both in flexure and in compression, grater values of free shrinkage and creep were also measured. From the obtained results it appears that the deformability of concrete with recycled aggregates can be estimated following the same criteria applied to concrete with natural aggregate, the differences in deformability can be justified considering the lower stiffness of the recycled aggregate
Mobility Disability in Older Adults: At the Intersection of People and Places
Mobility disability is associated with poor lower body function among older adults. This study examines whether specific types of neighborhood characteristics moderate that association
CcpA regulates arginine biosynthesis in Staphylococcus aureus through repression of proline catabolism.
Staphylococcus aureus is a leading cause of community-associated and nosocomial infections. Imperative to the success of S. aureus is the ability to adapt and utilize nutrients that are readily available. Genomic sequencing suggests that S. aureus has the genes required for synthesis of all twenty amino acids. However, in vitro experimentation demonstrates that staphylococci have multiple amino acid auxotrophies, including arginine. Although S. aureus possesses the highly conserved anabolic pathway that synthesizes arginine via glutamate, we demonstrate here that inactivation of ccpA facilitates the synthesis of arginine via the urea cycle utilizing proline as a substrate. Mutations within putA, rocD, arcB1, argG and argH abolished the ability of S. aureus JE2 ccpA::tetL to grow in the absence of arginine, whereas an interruption in argJBCF, arcB2, or proC had no effect. Furthermore, nuclear magnetic resonance demonstrated that JE2 ccpA::ermB produced (13)C(5) labeled arginine when grown with (13)C(5) proline. Taken together, these data support the conclusion that S. aureus synthesizes arginine from proline during growth on secondary carbon sources. Furthermore, although highly conserved in all sequenced S. aureus genomes, the arginine anabolic pathway (ArgJBCDFGH) is not functional under in vitro growth conditions. Finally, a mutation in argH attenuated virulence in a mouse kidney abscess model in comparison to wild type JE2 demonstrating the importance of arginine biosynthesis in vivo via the urea cycle. However, mutations in argB, argF, and putA did not attenuate virulence suggesting both the glutamate and proline pathways are active and they, or their pathway intermediates, can complement each other in vivo
Nuclease Modulates Biofilm Formation in Community-Associated Methicillin-Resistant Staphylococcus aureus
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is an emerging contributor to biofilm-related infections. We recently reported that strains lacking sigma factor B (sigB) in the USA300 lineage of CA-MRSA are unable to develop a biofilm. Interestingly, when spent media from a USA300 sigB mutant was incubated with other S. aureus strains, biofilm formation was inhibited. Following fractionation and mass spectrometry analysis, the major anti-biofilm factor identified in the spent media was secreted thermonuclease (Nuc). Considering reports that extracellular DNA (eDNA) is an important component of the biofilm matrix, we investigated the regulation and role of Nuc in USA300. The expression of the nuc gene was increased in a sigB mutant, repressed by glucose supplementation, and was unaffected by the agr quorum-sensing system. A FRET assay for Nuc activity was developed and confirmed the regulatory results. A USA300 nuc mutant was constructed and displayed an enhanced biofilm-forming capacity, and the nuc mutant also accumulated more high molecular weight eDNA than the WT and regulatory mutant strains. Inactivation of nuc in the USA300 sigB mutant background partially repaired the sigB biofilm-negative phenotype, suggesting that nuc expression contributes to the inability of the mutant to form biofilm. To test the generality of the nuc mutant biofilm phenotypes, the mutation was introduced into other S. aureus genetic backgrounds and similar increases in biofilm formation were observed. Finally, using multiple S. aureus strains and regulatory mutants, an inverse correlation between Nuc activity and biofilm formation was demonstrated. Altogether, our findings confirm the important role for eDNA in the S. aureus biofilm matrix and indicates Nuc is a regulator of biofilm formation
The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
While many classes of chemotherapeutic agents exist to treat solid tumors, few can generate a lasting response without substantial off-target toxicity despite significant scientific advancements and investments. In this review, the paths of development for nanoparticles, oncolytic viruses, and oncolytic bacteria over the last 20 years of research towards clinical translation and acceptance as novel cancer therapeutics are compared. Novel nanoparticle, oncolytic virus, and oncolytic bacteria therapies all start with a common goal of accomplishing therapeutic drug activity or delivery to a specific site while avoiding off-target effects, with overlapping methodology between all three modalities. Indeed, the degree of overlap is substantial enough that breakthroughs in one therapeutic could have considerable implications on the progression of the other two. Each oncotherapeutic modality has accomplished clinical translation, successfully overcoming the potential pitfalls promising therapeutics face. However, once studies enter clinical trials, the data all but disappears, leaving pre-clinical researchers largely in the dark. Overall, the creativity, flexibility, and innovation of these modalities for solid tumor treatments are greatly encouraging, and usher in a new age of pharmaceutical development
- …